Development of Predictive Statistical Model for Gaining Valuable Insights in Pharmaceutical Product Recalls
- PMID: 39443361
- DOI: 10.1208/s12249-024-02970-z
Development of Predictive Statistical Model for Gaining Valuable Insights in Pharmaceutical Product Recalls
Abstract
The rapid progress in artificial intelligence (AI) has revolutionized problem-solving across various domains. The global challenge of pharmaceutical product recalls imposes the development of effective tools to control and reduce shortage of pharmaceutical products and help avoid such recalls. This study employs AI, specifically machine learning (MI), to analyze critical factors influencing formulation, manufacturing, and formulation complexity which could offer promising avenue for optimizing drug development processes. Utilizing FDAZilla and SafeRX tools, an open database model was constructed, and predictive statistical models were developed using Multivariate Analysis and the Least Absolute Shrinkage and Selection Operator (LASSO) Approach. The study focuses on key descriptors such as delivery route, dosage form, dose, BCS classification, solid-state and physicochemical properties, release type, half-life, and manufacturing complexity. Through statistical analysis, a data simplification process identifies critical descriptors, assigning risk numbers and computing a cumulative risk number to assess product complexity and recall likelihood. Partial Least Square Regression and the LASSO approach established quantitative relationships between key descriptors and cumulative risk numbers. Results have identified key descriptors; BCS Class I, dose number, release profile, and drug half-life influencing product recall risk. The LASSO model further confirms these identified descriptors with 71% accuracy. In conclusion, the study presents a holistic AI and machine learning approach for evaluating and forecasting pharmaceutical product recalls, underscoring the importance of descriptors, formulation complexity, and manufacturing processes in mitigating risks associated with product quality.
Keywords: artificial intelligence; drug quality control; machine learning; multivariate analysis; pharmaceutical recalls; predictive modeling.
© 2024. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.
Similar articles
-
Artificial intelligence-driven pharmaceutical industry: A paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance.Eur J Pharm Sci. 2024 Dec 1;203:106938. doi: 10.1016/j.ejps.2024.106938. Epub 2024 Oct 16. Eur J Pharm Sci. 2024. PMID: 39419129 Review.
-
Artificial Intelligence in Drug Formulation and Development: Applications and Future Prospects.Curr Drug Metab. 2023;24(9):622-634. doi: 10.2174/0113892002265786230921062205. Curr Drug Metab. 2023. PMID: 37779408 Review.
-
The Identification of Quality Risk Factors for Non-biological Complex Drugs and Epilepsy Drugs Using Statistical Analysis of Formulation-Based Recalls in the USA.AAPS PharmSciTech. 2021 Dec 13;23(1):19. doi: 10.1208/s12249-021-02165-w. AAPS PharmSciTech. 2021. PMID: 34904204
-
The Artificial Intelligence-Powered New Era in Pharmaceutical Research and Development: A Review.AAPS PharmSciTech. 2024 Aug 15;25(6):188. doi: 10.1208/s12249-024-02901-y. AAPS PharmSciTech. 2024. PMID: 39147952 Review.
-
Artificial intelligence to deep learning: machine intelligence approach for drug discovery.Mol Divers. 2021 Aug;25(3):1315-1360. doi: 10.1007/s11030-021-10217-3. Epub 2021 Apr 12. Mol Divers. 2021. PMID: 33844136 Free PMC article. Review.
References
-
- Huggins CJPT. Drug recalls are more widespread than previously thought. Pharm Today. 2019;25(3):4. - DOI
-
- Wang B, Gagne JJ, Choudhry NK. The epidemiology of drug recalls in the United States. Arch Intern Med. 2012;172(14):1110–1. - DOI
-
- Sultan T, Rozin EH, Dave VS, Cetinkaya C. Non-destructive detection of disintegrant levels in compressed oral solid dosage forms. Int J Pharma. 2023;642:123171. - DOI
-
- Shah R, Ball GP, Netessine S. Plant operations and product recalls in the automotive industry: an empirical investigation. Manag Sci. 2017;63(8):2439–59. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources